世界の動物腫瘍市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Veterinary Oncology Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5020 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、動物腫瘍の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（手術、放射線、化学療法、免疫療法、その他（併用療法、分子標的療法））、用途別市場規模（イヌ科、ネコ科）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・動物腫瘍の市場動向 ・企業の競争状況、市場シェア ・動物腫瘍の種類別市場規模と予測2016-2027（手術、放射線、化学療法、免疫療法、その他（併用療法、分子標的療法）） ・動物腫瘍の用途別市場規模と予測2016-2027（イヌ科、ネコ科） ・動物腫瘍の北米市場規模2016-2027（アメリカ、カナダ） ・動物腫瘍の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・動物腫瘍のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・動物腫瘍の中南米市場規模2016-2027（メキシコ、ブラジル） ・動物腫瘍の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（PetCure Oncology、Accuray Incorporated、Varian Medical Systems、Boehringer Ingelheim、Elanco、Zoetis Karyopharm Therapeutics, Inc.、One Health、Regeneus Ltd.、Nippon Zenyaku Kogyo Co., Ltd.、Morphogenesis, Inc.、Karyopharm Therapeutics, Inc.） ・結論

Veterinary oncology is a subspecialty of veterinary medicine that deals with cancer diagnosis and treatment in animals.
Increasing pervasiveness of cancer in pet population and rising adoption of veterinary cancer therapy as a treatment method are propelling the market growth.

Market Analysis and Insights: Global Veterinary Oncology Market
The global Veterinary Oncology market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Veterinary Oncology market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Veterinary Oncology market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Veterinary Oncology market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Veterinary Oncology market.

Global Veterinary Oncology Scope and Market Size
Veterinary Oncology market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Veterinary Oncology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Surgery
Radiology
Chemotherapy
Immunotherapy
Others (Combination Therapy, Targeted Therapy)

Segment by Application
Canine
Feline

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
PetCure Oncology
Accuray Incorporated
Varian Medical Systems
Boehringer Ingelheim
Elanco
Zoetis Karyopharm Therapeutics, Inc.
One Health
Regeneus Ltd.
Nippon Zenyaku Kogyo Co., Ltd.
Morphogenesis, Inc.
Karyopharm Therapeutics, Inc.

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Veterinary Oncology Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Surgery
1.2.3 Radiology
1.2.4 Chemotherapy
1.2.5 Immunotherapy
1.2.6 Others (Combination Therapy, Targeted Therapy)
1.3 Market by Application
1.3.1 Global Veterinary Oncology Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Canine
1.3.3 Feline
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Veterinary Oncology Market Perspective (2016-2027)
2.2 Veterinary Oncology Growth Trends by Regions
2.2.1 Veterinary Oncology Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Veterinary Oncology Historic Market Share by Regions (2016-2021)
2.2.3 Veterinary Oncology Forecasted Market Size by Regions (2022-2027)
2.3 Veterinary Oncology Industry Dynamic
2.3.1 Veterinary Oncology Market Trends
2.3.2 Veterinary Oncology Market Drivers
2.3.3 Veterinary Oncology Market Challenges
2.3.4 Veterinary Oncology Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Veterinary Oncology Players by Revenue
3.1.1 Global Top Veterinary Oncology Players by Revenue (2016-2021)
3.1.2 Global Veterinary Oncology Revenue Market Share by Players (2016-2021)
3.2 Global Veterinary Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Veterinary Oncology Revenue
3.4 Global Veterinary Oncology Market Concentration Ratio
3.4.1 Global Veterinary Oncology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Veterinary Oncology Revenue in 2020
3.5 Veterinary Oncology Key Players Head office and Area Served
3.6 Key Players Veterinary Oncology Product Solution and Service
3.7 Date of Enter into Veterinary Oncology Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Veterinary Oncology Breakdown Data by Type
4.1 Global Veterinary Oncology Historic Market Size by Type (2016-2021)
4.2 Global Veterinary Oncology Forecasted Market Size by Type (2022-2027)

5 Veterinary Oncology Breakdown Data by Application
5.1 Global Veterinary Oncology Historic Market Size by Application (2016-2021)
5.2 Global Veterinary Oncology Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Veterinary Oncology Market Size (2016-2027)
6.2 North America Veterinary Oncology Market Size by Type
6.2.1 North America Veterinary Oncology Market Size by Type (2016-2021)
6.2.2 North America Veterinary Oncology Market Size by Type (2022-2027)
6.2.3 North America Veterinary Oncology Market Size by Type (2016-2027)
6.3 North America Veterinary Oncology Market Size by Application
6.3.1 North America Veterinary Oncology Market Size by Application (2016-2021)
6.3.2 North America Veterinary Oncology Market Size by Application (2022-2027)
6.3.3 North America Veterinary Oncology Market Size by Application (2016-2027)
6.4 North America Veterinary Oncology Market Size by Country
6.4.1 North America Veterinary Oncology Market Size by Country (2016-2021)
6.4.2 North America Veterinary Oncology Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Veterinary Oncology Market Size (2016-2027)
7.2 Europe Veterinary Oncology Market Size by Type
7.2.1 Europe Veterinary Oncology Market Size by Type (2016-2021)
7.2.2 Europe Veterinary Oncology Market Size by Type (2022-2027)
7.2.3 Europe Veterinary Oncology Market Size by Type (2016-2027)
7.3 Europe Veterinary Oncology Market Size by Application
7.3.1 Europe Veterinary Oncology Market Size by Application (2016-2021)
7.3.2 Europe Veterinary Oncology Market Size by Application (2022-2027)
7.3.3 Europe Veterinary Oncology Market Size by Application (2016-2027)
7.4 Europe Veterinary Oncology Market Size by Country
7.4.1 Europe Veterinary Oncology Market Size by Country (2016-2021)
7.4.2 Europe Veterinary Oncology Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Veterinary Oncology Market Size (2016-2027)
8.2 Asia-Pacific Veterinary Oncology Market Size by Type
8.2.1 Asia-Pacific Veterinary Oncology Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Veterinary Oncology Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Veterinary Oncology Market Size by Type (2016-2027)
8.3 Asia-Pacific Veterinary Oncology Market Size by Application
8.3.1 Asia-Pacific Veterinary Oncology Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Veterinary Oncology Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Veterinary Oncology Market Size by Application (2016-2027)
8.4 Asia-Pacific Veterinary Oncology Market Size by Region
8.4.1 Asia-Pacific Veterinary Oncology Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Veterinary Oncology Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Veterinary Oncology Market Size (2016-2027)
9.2 Latin America Veterinary Oncology Market Size by Type
9.2.1 Latin America Veterinary Oncology Market Size by Type (2016-2021)
9.2.2 Latin America Veterinary Oncology Market Size by Type (2022-2027)
9.2.3 Latin America Veterinary Oncology Market Size by Type (2016-2027)
9.3 Latin America Veterinary Oncology Market Size by Application
9.3.1 Latin America Veterinary Oncology Market Size by Application (2016-2021)
9.3.2 Latin America Veterinary Oncology Market Size by Application (2022-2027)
9.3.3 Latin America Veterinary Oncology Market Size by Application (2016-2027)
9.4 Latin America Veterinary Oncology Market Size by Country
9.4.1 Latin America Veterinary Oncology Market Size by Country (2016-2021)
9.4.2 Latin America Veterinary Oncology Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Veterinary Oncology Market Size (2016-2027)
10.2 Middle East & Africa Veterinary Oncology Market Size by Type
10.2.1 Middle East & Africa Veterinary Oncology Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Veterinary Oncology Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Veterinary Oncology Market Size by Type (2016-2027)
10.3 Middle East & Africa Veterinary Oncology Market Size by Application
10.3.1 Middle East & Africa Veterinary Oncology Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Veterinary Oncology Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Veterinary Oncology Market Size by Application (2016-2027)
10.4 Middle East & Africa Veterinary Oncology Market Size by Country
10.4.1 Middle East & Africa Veterinary Oncology Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Veterinary Oncology Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 PetCure Oncology
11.1.1 PetCure Oncology Company Details
11.1.2 PetCure Oncology Business Overview
11.1.3 PetCure Oncology Veterinary Oncology Introduction
11.1.4 PetCure Oncology Revenue in Veterinary Oncology Business (2016-2021)
11.1.5 PetCure Oncology Recent Development
11.2 Accuray Incorporated
11.2.1 Accuray Incorporated Company Details
11.2.2 Accuray Incorporated Business Overview
11.2.3 Accuray Incorporated Veterinary Oncology Introduction
11.2.4 Accuray Incorporated Revenue in Veterinary Oncology Business (2016-2021)
11.2.5 Accuray Incorporated Recent Development
11.3 Varian Medical Systems
11.3.1 Varian Medical Systems Company Details
11.3.2 Varian Medical Systems Business Overview
11.3.3 Varian Medical Systems Veterinary Oncology Introduction
11.3.4 Varian Medical Systems Revenue in Veterinary Oncology Business (2016-2021)
11.3.5 Varian Medical Systems Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Details
11.4.2 Boehringer Ingelheim Business Overview
11.4.3 Boehringer Ingelheim Veterinary Oncology Introduction
11.4.4 Boehringer Ingelheim Revenue in Veterinary Oncology Business (2016-2021)
11.4.5 Boehringer Ingelheim Recent Development
11.5 Elanco
11.5.1 Elanco Company Details
11.5.2 Elanco Business Overview
11.5.3 Elanco Veterinary Oncology Introduction
11.5.4 Elanco Revenue in Veterinary Oncology Business (2016-2021)
11.5.5 Elanco Recent Development
11.6 Zoetis Karyopharm Therapeutics, Inc.
11.6.1 Zoetis Karyopharm Therapeutics, Inc. Company Details
11.6.2 Zoetis Karyopharm Therapeutics, Inc. Business Overview
11.6.3 Zoetis Karyopharm Therapeutics, Inc. Veterinary Oncology Introduction
11.6.4 Zoetis Karyopharm Therapeutics, Inc. Revenue in Veterinary Oncology Business (2016-2021)
11.6.5 Zoetis Karyopharm Therapeutics, Inc. Recent Development
11.7 One Health
11.7.1 One Health Company Details
11.7.2 One Health Business Overview
11.7.3 One Health Veterinary Oncology Introduction
11.7.4 One Health Revenue in Veterinary Oncology Business (2016-2021)
11.7.5 One Health Recent Development
11.8 Regeneus Ltd.
11.8.1 Regeneus Ltd. Company Details
11.8.2 Regeneus Ltd. Business Overview
11.8.3 Regeneus Ltd. Veterinary Oncology Introduction
11.8.4 Regeneus Ltd. Revenue in Veterinary Oncology Business (2016-2021)
11.8.5 Regeneus Ltd. Recent Development
11.9 Nippon Zenyaku Kogyo Co., Ltd.
11.9.1 Nippon Zenyaku Kogyo Co., Ltd. Company Details
11.9.2 Nippon Zenyaku Kogyo Co., Ltd. Business Overview
11.9.3 Nippon Zenyaku Kogyo Co., Ltd. Veterinary Oncology Introduction
11.9.4 Nippon Zenyaku Kogyo Co., Ltd. Revenue in Veterinary Oncology Business (2016-2021)
11.9.5 Nippon Zenyaku Kogyo Co., Ltd. Recent Development
11.10 Morphogenesis, Inc.
11.10.1 Morphogenesis, Inc. Company Details
11.10.2 Morphogenesis, Inc. Business Overview
11.10.3 Morphogenesis, Inc. Veterinary Oncology Introduction
11.10.4 Morphogenesis, Inc. Revenue in Veterinary Oncology Business (2016-2021)
11.10.5 Morphogenesis, Inc. Recent Development
11.11 Karyopharm Therapeutics, Inc.
11.11.1 Karyopharm Therapeutics, Inc. Company Details
11.11.2 Karyopharm Therapeutics, Inc. Business Overview
11.11.3 Karyopharm Therapeutics, Inc. Veterinary Oncology Introduction
11.11.4 Karyopharm Therapeutics, Inc. Revenue in Veterinary Oncology Business (2016-2021)
11.11.5 Karyopharm Therapeutics, Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Veterinary Oncology Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Surgery
Table 3. Key Players of Radiology
Table 4. Key Players of Chemotherapy
Table 5. Key Players of Immunotherapy
Table 6. Key Players of Others (Combination Therapy, Targeted Therapy)
Table 7. Global Veterinary Oncology Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Veterinary Oncology Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Veterinary Oncology Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Veterinary Oncology Market Share by Regions (2016-2021)
Table 11. Global Veterinary Oncology Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Veterinary Oncology Market Share by Regions (2022-2027)
Table 13. Veterinary Oncology Market Trends
Table 14. Veterinary Oncology Market Drivers
Table 15. Veterinary Oncology Market Challenges
Table 16. Veterinary Oncology Market Restraints
Table 17. Global Veterinary Oncology Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Veterinary Oncology Market Share by Players (2016-2021)
Table 19. Global Top Veterinary Oncology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Veterinary Oncology as of 2020)
Table 20. Ranking of Global Top Veterinary Oncology Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Veterinary Oncology Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Veterinary Oncology Product Solution and Service
Table 24. Date of Enter into Veterinary Oncology Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Veterinary Oncology Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Veterinary Oncology Revenue Market Share by Type (2016-2021)
Table 28. Global Veterinary Oncology Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Veterinary Oncology Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Veterinary Oncology Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Veterinary Oncology Revenue Market Share by Application (2016-2021)
Table 32. Global Veterinary Oncology Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Veterinary Oncology Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Veterinary Oncology Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Veterinary Oncology Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Veterinary Oncology Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Veterinary Oncology Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Veterinary Oncology Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Veterinary Oncology Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Veterinary Oncology Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Veterinary Oncology Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Veterinary Oncology Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Veterinary Oncology Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Veterinary Oncology Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Veterinary Oncology Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Veterinary Oncology Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Veterinary Oncology Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Veterinary Oncology Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Veterinary Oncology Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Veterinary Oncology Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Veterinary Oncology Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Veterinary Oncology Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Veterinary Oncology Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Veterinary Oncology Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Veterinary Oncology Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Veterinary Oncology Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Veterinary Oncology Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Veterinary Oncology Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Veterinary Oncology Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Veterinary Oncology Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Veterinary Oncology Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Veterinary Oncology Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Veterinary Oncology Market Size by Country (2022-2027) & (US$ Million)
Table 64. PetCure Oncology Company Details
Table 65. PetCure Oncology Business Overview
Table 66. PetCure Oncology Veterinary Oncology Product
Table 67. PetCure Oncology Revenue in Veterinary Oncology Business (2016-2021) & (US$ Million)
Table 68. PetCure Oncology Recent Development
Table 69. Accuray Incorporated Company Details
Table 70. Accuray Incorporated Business Overview
Table 71. Accuray Incorporated Veterinary Oncology Product
Table 72. Accuray Incorporated Revenue in Veterinary Oncology Business (2016-2021) & (US$ Million)
Table 73. Accuray Incorporated Recent Development
Table 74. Varian Medical Systems Company Details
Table 75. Varian Medical Systems Business Overview
Table 76. Varian Medical Systems Veterinary Oncology Product
Table 77. Varian Medical Systems Revenue in Veterinary Oncology Business (2016-2021) & (US$ Million)
Table 78. Varian Medical Systems Recent Development
Table 79. Boehringer Ingelheim Company Details
Table 80. Boehringer Ingelheim Business Overview
Table 81. Boehringer Ingelheim Veterinary Oncology Product
Table 82. Boehringer Ingelheim Revenue in Veterinary Oncology Business (2016-2021) & (US$ Million)
Table 83. Boehringer Ingelheim Recent Development
Table 84. Elanco Company Details
Table 85. Elanco Business Overview
Table 86. Elanco Veterinary Oncology Product
Table 87. Elanco Revenue in Veterinary Oncology Business (2016-2021) & (US$ Million)
Table 88. Elanco Recent Development
Table 89. Zoetis Karyopharm Therapeutics, Inc. Company Details
Table 90. Zoetis Karyopharm Therapeutics, Inc. Business Overview
Table 91. Zoetis Karyopharm Therapeutics, Inc. Veterinary Oncology Product
Table 92. Zoetis Karyopharm Therapeutics, Inc. Revenue in Veterinary Oncology Business (2016-2021) & (US$ Million)
Table 93. Zoetis Karyopharm Therapeutics, Inc. Recent Development
Table 94. One Health Company Details
Table 95. One Health Business Overview
Table 96. One Health Veterinary Oncology Product
Table 97. One Health Revenue in Veterinary Oncology Business (2016-2021) & (US$ Million)
Table 98. One Health Recent Development
Table 99. Regeneus Ltd. Company Details
Table 100. Regeneus Ltd. Business Overview
Table 101. Regeneus Ltd. Revenue in Veterinary Oncology Business (2016-2021) & (US$ Million)
Table 102. Regeneus Ltd. Recent Development
Table 103. Nippon Zenyaku Kogyo Co., Ltd. Company Details
Table 104. Nippon Zenyaku Kogyo Co., Ltd. Business Overview
Table 105. Nippon Zenyaku Kogyo Co., Ltd. Veterinary Oncology Product
Table 106. Nippon Zenyaku Kogyo Co., Ltd. Revenue in Veterinary Oncology Business (2016-2021) & (US$ Million)
Table 107. Nippon Zenyaku Kogyo Co., Ltd. Recent Development
Table 108. Morphogenesis, Inc. Company Details
Table 109. Morphogenesis, Inc. Business Overview
Table 110. Morphogenesis, Inc. Veterinary Oncology Product
Table 111. Morphogenesis, Inc. Revenue in Veterinary Oncology Business (2016-2021) & (US$ Million)
Table 112. Morphogenesis, Inc. Recent Development
Table 113. Karyopharm Therapeutics, Inc. Company Details
Table 114. Karyopharm Therapeutics, Inc. Business Overview
Table 115. Karyopharm Therapeutics, Inc. Veterinary Oncology Product
Table 116. Karyopharm Therapeutics, Inc. Revenue in Veterinary Oncology Business (2016-2021) & (US$ Million)
Table 117. Karyopharm Therapeutics, Inc. Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Veterinary Oncology Market Share by Type: 2020 VS 2027
Figure 2. Surgery Features
Figure 3. Radiology Features
Figure 4. Chemotherapy Features
Figure 5. Immunotherapy Features
Figure 6. Others (Combination Therapy, Targeted Therapy) Features
Figure 7. Global Veterinary Oncology Market Share by Application: 2020 VS 2027
Figure 8. Canine Case Studies
Figure 9. Feline Case Studies
Figure 10. Veterinary Oncology Report Years Considered
Figure 11. Global Veterinary Oncology Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Veterinary Oncology Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Veterinary Oncology Market Share by Regions: 2020 VS 2027
Figure 14. Global Veterinary Oncology Market Share by Regions (2022-2027)
Figure 15. Global Veterinary Oncology Market Share by Players in 2020
Figure 16. Global Top Veterinary Oncology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Veterinary Oncology as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Veterinary Oncology Revenue in 2020
Figure 18. Global Veterinary Oncology Revenue Market Share by Type (2016-2021)
Figure 19. Global Veterinary Oncology Revenue Market Share by Type (2022-2027)
Figure 20. North America Veterinary Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Veterinary Oncology Market Share by Type (2016-2027)
Figure 22. North America Veterinary Oncology Market Share by Application (2016-2027)
Figure 23. North America Veterinary Oncology Market Share by Country (2016-2027)
Figure 24. United States Veterinary Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Veterinary Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Veterinary Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Veterinary Oncology Market Share by Type (2016-2027)
Figure 28. Europe Veterinary Oncology Market Share by Application (2016-2027)
Figure 29. Europe Veterinary Oncology Market Share by Country (2016-2027)
Figure 30. Germany Veterinary Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Veterinary Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Veterinary Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Veterinary Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Veterinary Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Veterinary Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Veterinary Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Veterinary Oncology Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Veterinary Oncology Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Veterinary Oncology Market Share by Region (2016-2027)
Figure 40. China Veterinary Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Veterinary Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Veterinary Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Veterinary Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Veterinary Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Veterinary Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Veterinary Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Veterinary Oncology Market Share by Type (2016-2027)
Figure 48. Latin America Veterinary Oncology Market Share by Application (2016-2027)
Figure 49. Latin America Veterinary Oncology Market Share by Country (2016-2027)
Figure 50. Mexico Veterinary Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Veterinary Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Veterinary Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Veterinary Oncology Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Veterinary Oncology Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Veterinary Oncology Market Share by Country (2016-2027)
Figure 56. Turkey Veterinary Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Veterinary Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Veterinary Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. PetCure Oncology Revenue Growth Rate in Veterinary Oncology Business (2016-2021)
Figure 60. Accuray Incorporated Revenue Growth Rate in Veterinary Oncology Business (2016-2021)
Figure 61. Varian Medical Systems Revenue Growth Rate in Veterinary Oncology Business (2016-2021)
Figure 62. Boehringer Ingelheim Revenue Growth Rate in Veterinary Oncology Business (2016-2021)
Figure 63. Elanco Revenue Growth Rate in Veterinary Oncology Business (2016-2021)
Figure 64. Zoetis Karyopharm Therapeutics, Inc. Revenue Growth Rate in Veterinary Oncology Business (2016-2021)
Figure 65. One Health Revenue Growth Rate in Veterinary Oncology Business (2016-2021)
Figure 66. Regeneus Ltd. Revenue Growth Rate in Veterinary Oncology Business (2016-2021)
Figure 67. Nippon Zenyaku Kogyo Co., Ltd. Revenue Growth Rate in Veterinary Oncology Business (2016-2021)
Figure 68. Morphogenesis, Inc. Revenue Growth Rate in Veterinary Oncology Business (2016-2021)
Figure 69. Karyopharm Therapeutics, Inc. Revenue Growth Rate in Veterinary Oncology Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

---